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Background
The Presenilin-1 gene (PSEN-1) encodes a protein com-
ponent of gamma-secretase complex which is involved
in processing of amyloid precursor protein (APP). The
PSEN-1 is involved in many cardinal mechanisms in
several molecular pathway which when impaired leads
to the manifestation of Alzheimer’s disease (AD). The
aim of the study was to investigate the role of PSEN-1
gene in the developement of AD in Indian Bengali
population.
Materials and methods
Blood samples were collected from 96 AD patients and
173 age matched control individuals. DNA was isolated
from each sample and then sequencing was performed
for the exon 8 and its flanking introns of PSEN-1 gene.
Results
A rare mutation rs201992645 was identified within
intron 8 and several in. silico analyses (Bioinformatic
tools like ‘Human Splicing Finder’, ‘SpliceAid’ and
‘mutation t@sting’) revealed the mutation as ‘potentially
damaging’ at the transcript splicing level. The genotypic
frequencies of mutant heterozygotes were 0.031 AD, but
it was not found in the control population.
Conclusions
We hypothesize that this rare mutation may be involved in
the malfunctioning of Presenilin-1 protein and thus may
play a role in the manifestation of Alzheimer’s disease.
Further study with large population size may establish this
mutation as a potential biomarker for diagnosis of AD.
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